We are live on ! Find out more
BOLD

Boundless Bio

55 hedge funds and large institutions have $37.6M invested in Boundless Bio in 2024 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 28 increasing their positions, 4 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 4

0% more funds holding

Funds holding: 5555 (0)

0% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 9

1.51% less ownership

Funds ownership: 59.64%58.13% (-1.5%)

18% less capital invested

Capital invested by funds: $46.1M → $37.6M (-$8.48M)

Holders
55
Holders Change
Holders Change %
0%
% of All Funds
0.72%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
28
Reduced
4
Closed
9
Calls
Puts
Net Calls
Net Calls Change

BOLD Hedge Fund Activity: Q4 2024 in Review

55 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Boundless Bio (BOLD) for Q4 2024, worth a combined $37.6M — down 18% from $46.1M a quarter earlier.

Fund positioning in BOLD was balanced in Q4 2024: 9 funds opened new positions, 9 closed out, 28 added to existing stakes and 4 trimmed.

The largest buyer was BlackRock, adding an estimated $701K. The largest seller was Wellington Management Group, cutting an estimated $1.14M.

  • 55 institutional investors held Boundless Bio (BOLD) as of Q4 2024, unchanged from Q3 2024.
  • Funds reported $37.6M of Boundless Bio stock for Q4 2024, down 18% quarter-over-quarter.
  • 9 funds opened new Boundless Bio positions in Q4 2024 and 9 closed out, a net change of 0 holders.
  • The largest Boundless Bio buyer in Q4 2024 was BlackRock, an estimated $701K added.
  • The largest Boundless Bio seller in Q4 2024 was Wellington Management Group, an estimated $1.14M sold.

Based on aggregated 13F filings for Q4 2024.